Skip to content
News Center
About Us Careers News Center Contact Us Legal Video Hub iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts Illumina for Startups Home

Community

2020 Vision for Genomics

Looking forward, Dr. Eric Green talks to Illumina about the future of genomics

2020 Vision for Genomics
1 June 2018

The National Human Genome Research Institute (NHGRI) launched a new round of strategic planning to establish a 2020 vision for genomics. In celebration of National DNA Day 2018, Dr. Eric Green, Director of the NHGRI, joins us for a discussion of the Human Genome Project, the state of genomics today and where genomics is likely headed in the future.

Listen to the podcast, here.

 

Like podcasts? Curious about genomics? Discover more Illumina-produced podcasts, here.

Previous Article
Next Article

Recent Articles

How the UK is setting new standards for genomic research and better health care
How the UK is setting new standards for genomic research and better health care
Merging discovery with clinical care at Ontario Institute for Cancer Research
Video: Merging discovery with clinical care at Ontario Institute for Cancer Research
Preventing postoperative infections one NGS assay at a time
Preventing postoperative infections one NGS assay at a time
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2023 Illumina, Inc. All rights reserved.